Universe Pharmaceuticals ...

NASDAQ: UPC · Real-Time Price · USD
3.54
-0.02 (-0.56%)
At close: Aug 15, 2025, 12:12 PM

Universe Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
29.5M 5.29M 5.71M 8.08M
Short-Term Investments
n/a 13.22M 13.15M 13.73M
Long-Term Investments
712.49K 685.31K 702.89K 744.92K
Other Long-Term Assets
n/a 35.86K 2.25M 2.48M
Receivables
17.88M 12.52M 15.18M 15.81M
Inventory
1.74M 3.34M 2.21M 2.46M
Other Current Assets
852.42K -1.16M 1.72M 174.05K
Total Current Assets
51.64M 36.81M 41.51M 50.48M
Property-Plant & Equipment
15.34M 14.99M 13.58M 15.39M
Goodwill & Intangibles
262.88K 148.58K 157.45K 178.48K
Total Long-Term Assets
16.32M 16.45M 18.03M 19.66M
Total Assets
67.95M 53.29M 59.54M 70.14M
Account Payables
4.91M 4.59M 3.08M 5.31M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
5.86M 5.48M 3.94M 4.33M
Other Current Liabilities
n/a n/a 3.38M n/a
Total Current Liabilities
20.31M 13.75M 13.1M 11.21M
Long-Term Debt
2.14M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
2.14M n/a 7.01M n/a
Total Liabilities
22.45M 13.75M 13.1M 11.21M
Total Debt
7.99M 5.48M 3.94M 4.33M
Common Stock
482.4K 67.97K 67.97K 67.97K
Retained Earnings
-10.17M 10.16M 16.32M 25.06M
Comprehensive Income
1.33M 26.27K 772.83K 4.53M
Shareholders Equity
45.5M 39.53M 46.44M 58.93M
Total Investments
712.49K 13.9M 13.85M 14.47M